Tag: the war on (some) drugs

Oregon’s Appetite for Psilocybin Is Being Fed Outside the Law in the Mushroom Underground

Three thousand five hundred dollars.

That’s how much it’s going to cost to swallow 4 grams of psilocybin mushrooms and undergo a six-hour therapy session at EPIC Healing Eugene—if and when the clinic gets its license to run a “psilocybin service center” and its owner, Cathy Jonas, gets her facilitator license after undergoing 300 hours of training and passing a state-mandated test.

Together, those two licenses will cost her $12,000 a year. On top of that, she must spend thousands on a security system, liability insurance, and a 375-pound safe. All in, Jonas estimates she’ll spend $60,000 to open her service center and, at $3,500 a session, she expects to barely break even. “They have really made this hard,” Jonas, 56, says.

Two and a half years ago, Oregon voters approved Measure 109, making Oregon the first state in the nation to legalize the supervised use of psilocybin mushrooms. But that freedom comes with fine print. The program requires users to trip only in the presence of a trained facilitator in a service center using psilocybin grown by state-approved manufacturers and tested by state-licensed labs.

All of that adds costs. The result is a price tag that’s going to astonish the fungi-curious. A single session—5 grams, six hours—will cost more than the median Oregonian’s biweekly take-home pay.

Still willing to pony up? Sorry, get in line. At press time, no service centers—the only places you’re allowed to take psilocybin legally—had been licensed by the Oregon Health Authority. Three manufacturers, one testing lab, and just four facilitators had been licensed as of April 25.

In other words, the ballot measure created an appetite that the regulated system seems unprepared to satisfy. The outcome? The legalization of psilocybin mushrooms in Oregon is spurring an expansion of the decades-old illegal market.

Keep reading

Entire Warner Robins Narcotics Unit placed on leave over misconduct investigation

The Warner Robins Police Department has put its entire drug unit on administrative leave over an investigation into allegations of misconduct.

In a press release sent shortly before noon on Monday, the Houston County District Attorney said on the evening of April 11, they were notified of allegations involving members of the department’s Narcotics Investigation Unit.

The next day, the DA’s office began an investigation and notified Warner Robins Police Chief Roy Whitehead.

According to officials, Whitehead placed the department on administrative leave “out of caution” and no charges have been filed at this point in the investigation.

Keep reading

Delaware Just Became the 22nd State To Legalize Recreational Marijuana

Delaware just became the 22nd state to legalize recreational marijuana. On Friday, Gov. John Carney, a Democrat, said he will allow two legalization bills to take effect without his signature, notwithstanding his continued concerns about the consequences of lifting Delaware’s ban on recreational use.

“After years of advocacy, collaboration, and grassroots organizing, we are thrilled to see cannabis legalization become a reality in our state,” Laura Sharer, executive director of the Delaware chapter of the National Organization for the Reform of Marijuana Laws, said in a press release. “This victory is a result of the tireless work of thousands of volunteers, dozens of lawmakers, and with the support of a huge majority of our Delaware community. So many have championed this righteous cause and recognized the need for sensible cannabis policy reform.”

Delaware has allowed medical use of marijuana since 2011, and in 2015 legislators decriminalized possession of an ounce or less, making it a civil offense punishable by a $100 fine. Carney supports both of those policies but has previously resisted efforts to go further. Last year he vetoed recreational legalization. The Democrat-controlled Delaware General Assembly recently approved essentially the same legislation that Carney blocked last year, this time by larger margins, making it more likely that a veto would be overridden.

Keep reading

UK university launches postgraduate course in clinical use of psychedelics

A UK university is launching one of the world’s first postgraduate qualifications on psychedelics to teach healthcare workers about using psilocybin, LSD, MDMA and other psychoactive drugs in therapeutic work.

The certificate from Exeter University cements psychedelics as an area of scientific importance in the UK. It could help pave the way for clinical therapies becoming available within the next five years, with some treatments being in the final stages of clinical trials.

This would follow Australia, which has become the first country to allow psychiatrists to prescribe psychedelics for treatment-resistant depression. In the US, MDMA may be licensed to treat post-traumatic stress disorder by the end of the year, and Oregon and Colorado are planning to legalise the regulated use of psilocybin, the hallucinogenic chemical found in magic mushrooms.

Celia Morgan, a professor of psychopharmacology at the University of Exeter and a co-lead of the programme, said: “As the world wakes up to the potential for psychedelics to be an important part of the toolkit to treat some of our most damaging mental health conditions, it’s vital that we’re training the workforce to meet the demand. The global body of high-quality evidence is now irrefutable – psychedelics can work where other treatments have failed.”

Noting that the main barriers to their use were legal and structural rather than medical, she added: “I think this shows how far we have come from the fear and stigma that dogged this field for years, a change which we also see reflected in leading universities around the world conducting gold-standard clinical trials.

Keep reading

Helping veterans, battling opioid addiction driving magic mushroom legislation progress

Forty lawmakers, 36 Democrats and 4 Republicans, have co-sponsored a bill aiming to allow for the medical use of psilocybin and a psilocybin therapy grant program, which is currently sitting at the committee level of the Assembly, with its Senate version also in committee. The Assembly bill, A03581, was introduced by Democrat Pat Burke in February. There has been other legislation introduced regarding the hallucinogen as well, with Linda Rosenthal’s version legalizing the adult possession and use of hallucinogens like it.

Research has shown that psilocybin, an organic psychedelic compound, can benefit people with cluster headaches, depression, anxiety, irritable bowel syndrome, ADHD and obsessive compulsive disorder, but it’s getting the most universal traction because of its impact on those suffering from PTSD.

“Psilocybin doesn’t have the huge appeal that marijuana had,” Democrat Assemblyman Phil Steck, who is the Assembly’s Chairman of the Alcoholism and Drug Abuse Committee, says. “But, there are definitely people who make a strong case for the proposition that it helps with PTSD. Certainly we want to do everything that we can to help people that are coming back from war, and if psilocybin has proven to do that, then it should be legal for that purpose.”

Johns Hopkins University has conducted several studies on psilocybin, saying it has substantial antidepressant effects, but needs to be administered under carefully controlled conditions through trained clinicians and therapists.

Keep reading

Prohibition Gave Us Xylazine in Fentanyl. The Solution, Drug Warriors Say, Is More Prohibition.

The emergence of the animal tranquilizer xylazine as a fentanyl adulterant, like the emergence of fentanyl as a heroin booster and substitute, has prompted law enforcement officials to agitate for new legal restrictions and criminal penalties. That response is fundamentally misguided, because the threat it aims to address is a familiar consequence of prohibition, which creates a black market in which drug composition is highly variable and unpredictable. Instead of recognizing their complicity in maintaining and magnifying that hazard, drug warriors always think the answer is more of the same.

Xylazine was first identified as a fentanyl adulterant in 2006, and today it is especially common in Puerto Rico, Philadelphia, Maryland, and Connecticut. In Philadelphia between 2010 and 2015, according to a 2021 BMJ article, xylazine was detected in less than 2 percent of drug-related deaths involving heroin and/or fentanyl. Its prevalence in such cases had risen to 31 percent by 2019. According to a 2022 Cureus report, “up to 78%” of illicit fentanyl sold in Puerto Rico and Philadelphia contains xylazine. In 2022, the Drug Enforcement Administration (DEA) reports, xylazine was detected in 23 percent of fentanyl powder and 7 percent of fentanyl pills analyzed by its laboratories.

Xylazine is a sedative, analgesic, and muscle relaxant that is not approved for use in humans but is commonly used by veterinarians. It is chemically similar to phenothiazines, tricyclic antidepressants, and clonidine. But like fentanyl and other opioids, xylazine depresses respiration, so combining it with narcotics can increase the risk of a fatal reaction. Unlike a fentanyl overdose, a xylazine overdose cannot be reversed by the opioid antagonist naloxone.

Xylazine also seems to increase the risk of potentially serious skin infections and ulcers that have always been a hazard of unsanitary injection practices. According to a 2022 article in Dermatology World Insights and Inquiries, “the presumed mechanism” is “the direct vasoconstricting effect on local blood vessels and resultant decreased skin perfusion,” which impairs healing.

Why is xylazine showing up in fentanyl? For the same reasons fentanyl started showing up in heroin. As a 2014 literature review in Forensic Science International notes, “illicit drugs, such as cocaine and heroin, are often adulterated with other agents to increase bulk and enhance or mimic the illicit drug’s effects.” Because xylazine and heroin have “some similar pharmacologic effects,” the authors say, “synergistic effects may occur in humans when xylazine is use as an adulterant of heroin.”

Keep reading

US could soon approve MDMA therapy — opening an era of psychedelic medicine

For Rick Doblin, 2023 could be a landmark year: the year that the US government decides whether it will allow the use of hallucinogenic drugs to treat mental illness.

Doblin, who is based in Belmont, Massachusetts, is the founder and president of the non-profit organization Multidisciplinary Association for Psychedelic Studies (MAPS). He has spent nearly 40 years researching whether the experience produced by the psychedelic drug MDMA — also called ecstasy or molly — can help people with post-traumatic stress disorder (PTSD). In 2021, MAPS’s phase III clinical trial of 90 people with PTSD found that those who received MDMA coupled with psychotherapy were twice as likely to recover from the condition as were those who received psychotherapy with a placebo1 (see ‘Response to MDMA therapy’).

Keep reading

HOW CALIFORNIA COPS EXPLOIT LEGAL GRAY AREAS TO CONTINUE THEIR WAR ON CANNABIS

Years after legalization, the state’s growers say police are taking a “seize first, ask questions later” mentality toward marijuana enforcement, sometimes with heavily militarized operations that allegedly violate their rights.

Zeke Flatten was driving southbound on Highway 101 in Northern California in December 2017 when he was pulled over by an unmarked SUV with flashing emergency lights.

Two officers clad in green, military-style garb and bulletproof vests approached Flatten’s vehicle but didn’t identify themselves. After asking Flatten if he knew how fast he was going, one of the men told him they suspected he was transporting cannabis, according to court documents. Flatten was immediately suspicious.

“He never mentioned anything else about the reason, probable cause, why he stopped me,” Flatten said in an interview with The Appeal.

The officers were correct, however: Flatten, a film producer and former undercover cop who’d temporarily relocated to Northern California, had three pounds of marijuana, including a few rolled joints, in the car—worth over $3,000 at the time. Flatten says he was working on a number of cannabis-related projects and was driving to a lab to test the weed, which he’d hoped to sell legally.

Just over a year before the stop, California had voted to legalize the personal cultivation and possession of up to an ounce of marijuana with the passage of Proposition 64. Under the measure, possession of larger amounts of cannabis was reduced from a felony offense to a misdemeanor, punishable by up to six months of incarceration and a maximum $500 fine.

But marijuana remains illegal at the federal level, classified as a Schedule 1 substance alongside drugs like heroin, LSD, and MDMA, known as Ecstasy. When the officers identified themselves as members of the Bureau of Alcohol, Tobacco, Firearms and Explosives (ATF), a federal agency, Flatten said he started to realize something was off.

“There’s no patches, there’s no badges, there’s no name tags,” Flatten said.

Flatten says he offered to show the officers his medical marijuana card, which should have allowed him to have the cannabis. But they didn’t want to look at the card. He figured if the agents believed the marijuana was illegal, they’d take it and provide him a receipt for the seizure, which would give him a chance to argue his case in court, Flatten said.

Instead, they proceeded to confiscate the cannabis from the back of Flatten’s car without running his name for warrants, or issuing a traffic ticket, court summons, or even documentation of the seizure, Flatten said. The officers did tell him that he might be getting a letter from the federal government. But he never did.

Flatten said he felt like he’d been robbed. He started looking for a lawyer, and a few days later, went to the Mendocino County Sheriff’s Department to report the incident. The next week, after returning to his home state of Texas, he made an official report at the FBI field office in San Antonio.

He would soon find out that the officers who seized his marijuana weren’t actually ATF agents. Flatten alleges one was a member of the sheriff’s department. The other was from the Rohnert Park Police Department, and has since been indicted on federal charges including extortion and conspiracy in connection with cannabis seizures.

Keep reading

New York City Should Have Always Smelled Like Pot

“​​The degree to which Manhattan air is now just saturated with the aroma of marijuana is frankly absurd,” tweeted writer Thomas Chatterton Williams back in January. “New York Smells Like a Declining City,” declared The Wall Street Journal last month. “It’s like everybody’s smoking a joint now,” New York City’s own mayor, Eric Adams, commented last year.

Though New York state legalized recreational weed in 2021, it’s taken two years for the cannabis industry to actually get it off the ground. Just a few dispensaries have opened up in the city so far, but much has been made about its alleged transformation into either a Reefer Madness hellscape or a stoner Xanadu, depending on who you ask.

“Let’s be blunt—legal weed is turning New York workers into zombies,” wrote Steve Cuozzo for the New York Post just days ago, complaining of worse customer service than he encountered yesteryear. “the weed / garbage / piss cocktail of smells in parts of manhattan is truly nauseating,” one Twitter user chimed in. “The biggest change is the smell of marijuana. It’s EVERYWHERE. Inescapable. It’s made the city a lot grimier, and much more unsafe,” added another.

Now that they no longer have to fear arrest, more people may indeed be lighting up in public. As with many things in New York, private behavior—a couple’s fight, a parent disciplining their child, a group of friends who are too boisterously drunk—spills into public spaces. We’re tasked with learning how to tolerate, or at least look past, the low-grade deviancy and etiquette missteps we encounter in streets and subway stations, shared hallways and stoops. “For the record, I don’t care if people smoke (or drink!), but the imposition of the odor all over public spaces is weird and feels deeply unserious,” Chatterton Williams (one of the more reasonable pot critics) added.

Still, many of the tweets and articles in this genre clumsily attempt to underscore the same idea: New York is getting worse by the day—and pot must be to blame.

But the aroma of weed in the air ought to be interpreted as people relishing their newfound freedom, a sign that tolerance toward people’s mind-alteration preferences has rightfully prevailed.

Keep reading

Celebrating The 80th Anniversary Of Bicycle Day: A Different Kind Of Trip

Every year, on April 19, an important anniversary rolls around that you may never have heard of. To those in the know, it’s called Bicycle Day, and it commemorates the first-ever intentional LSD trip. 

It all started when a Swiss chemist called Albert Hofmann had a very peculiar time while cycling home from the lab. Hofmann was the first person to synthesize LSD back in 1938. He did it by isolating chemical compounds found in a fungus called ergot, which infects grasses like rye and can have some profound effects on any humans unfortunate enough to accidentally consume it.

It’s safe to say that Hofmann didn’t think much of his discovery to begin with. What we now know as LSD was actually the 25th in a long line of similar compounds that he’d been experimenting with, and Hofmann’s research notes from the time reportedly reveal how no one was particularly enthused by it: “The new substance, however, aroused no special interest in our pharmacologists and physicians; testing was therefore discontinued.”

Keep reading